1
|
Chen M, Hei J, Huang Y, Liu X, Huang Y. In vivo safety evaluation method for nanomaterials for cancer therapy. Clin Transl Oncol 2024; 26:2126-2141. [PMID: 38573443 DOI: 10.1007/s12094-024-03466-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2024] [Accepted: 03/13/2024] [Indexed: 04/05/2024]
Abstract
Nanomaterials are extensively used in the diagnosis and treatment of cancer and other diseases because of their distinctive physicochemical properties, including the small size and ease of modification. The approval of numerous nanomaterials for clinical treatment has led to a significant increase in human exposure to these materials. When nanomaterials enter organisms, they interact with DNA, cells, tissues, and organs, potentially causing various adverse effects, such as genotoxicity, reproductive toxicity, immunotoxicity, and damage to tissues and organs. Therefore, it is crucial to elucidate the side effects and toxicity mechanisms of nanomaterials thoroughly before their clinical applications. Although methods for in vitro safety evaluation of nanomaterials are well established, systematic methods for in vivo safety evaluation are still lacking. This review focuses on the in vivo safety evaluation of nanomaterials and explores their potential effects. In addition, the experimental methods for assessing such effects in various disciplines, including toxicology, pharmacology, physiopathology, immunology, and bioinformatics are also discussed.
Collapse
Affiliation(s)
- Mengqi Chen
- State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, 530021, Guangxi, China
| | - Jingyi Hei
- State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, 530021, Guangxi, China
| | - Yan Huang
- State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, 530021, Guangxi, China
| | - Xiyu Liu
- State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, 530021, Guangxi, China.
| | - Yong Huang
- State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, 530021, Guangxi, China.
| |
Collapse
|
2
|
Di Cristo L, Ude VC, Tsiliki G, Tatulli G, Romaldini A, Murphy F, Wohlleben W, Oomen AG, Pompa PP, Arts J, Stone V, Sabella S. Grouping of orally ingested silica nanomaterials via use of an integrated approach to testing and assessment to streamline risk assessment. Part Fibre Toxicol 2022; 19:68. [PMID: 36461106 PMCID: PMC9719179 DOI: 10.1186/s12989-022-00508-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2022] [Accepted: 11/21/2022] [Indexed: 12/05/2022] Open
Abstract
BACKGROUND Nanomaterials can exist in different nanoforms (NFs). Their grouping may be supported by the formulation of hypotheses which can be interrogated via integrated approaches to testing and assessment (IATA). IATAs are decision trees that guide the user through tiered testing strategies (TTS) to collect the required evidence needed to accept or reject a grouping hypothesis. In the present paper, we investigated the applicability of IATAs for ingested NFs using a case study that includes different silicon dioxide, SiO2 NFs. Two oral grouping hypotheses addressing local and systemic toxicity were identified relevant for the grouping of these NFs and verified through the application of oral IATAs. Following different Tier 1 and/or Tier 2 in vitro methods of the TTS (i.e., in vitro dissolution, barrier integrity and inflammation assays), we generated the NF datasets. Furthermore, similarity algorithms (e.g., Bayesian method and Cluster analysis) were utilized to identify similarities among the NFs and establish a provisional group(s). The grouping based on Tier 1 and/or Tier 2 testing was analyzed in relation to available Tier 3 in vivo data in order to verify if the read-across was possible and therefore support a grouping decision. RESULTS The measurement of the dissolution rate of the silica NFs in the oro-gastrointestinal tract and in the lysosome identified them as gradually dissolving and biopersistent NFs. For the local toxicity to intestinal epithelium (e.g. cytotoxicity, membrane integrity and inflammation), the biological results of the gastrointestinal tract models indicate that all of the silica NFs were similar with respect to the lack of local toxicity and, therefore, belong to the same group; in vivo data (although limited) confirmed the lack of local toxicity of NFs. For systemic toxicity, Tier 1 data did not identify similarity across the NFs, with results across different decision nodes being inconsistent in providing homogeneous group(s). Moreover, the available Tier 3 in vivo data were also insufficient to support decisions based upon the obtained in vitro results and relating to the toxicity of the tested NFs. CONCLUSIONS The information generated by the tested oral IATAs can be effectively used for similarity assessment to support a grouping decision upon the application of a hypothesis related to toxicity in the gastrointestinal tract. The IATAs facilitated a structured data analysis and, by means of the expert's interpretation, supported read-across with the available in vivo data. The IATAs also supported the users in decision making, for example, reducing the testing when the grouping was well supported by the evidence and/or moving forward to advanced testing (e.g., the use of more suitable cellular models or chronic exposure) to improve the confidence level of the data and obtain more focused information.
Collapse
Affiliation(s)
- Luisana Di Cristo
- grid.25786.3e0000 0004 1764 2907D3 PharmaChemistry, Nanoregulatory Group, Italian Institute of Technology, Via Morego, 30, 16163 Genoa, Italy
| | - Victor C. Ude
- grid.9531.e0000000106567444Nano Safety Research Group, School of Engineering and Physical Sciences, Heriot Watt University, Edinburgh, EH14 4AS UK
| | - Georgia Tsiliki
- grid.19843.370000 0004 0393 5688Institute for the Management of Information Systems, Athena Research Center, Marousi, Greece
| | - Giuseppina Tatulli
- grid.25786.3e0000 0004 1764 2907Nanobiointeractions & Nanodiagnostics, Istituto Italiano Di Tecnologia (IIT), Via Morego, 30, 16163 Genoa, Italy
| | - Alessio Romaldini
- grid.25786.3e0000 0004 1764 2907D3 PharmaChemistry, Nanoregulatory Group, Italian Institute of Technology, Via Morego, 30, 16163 Genoa, Italy
| | - Fiona Murphy
- grid.9531.e0000000106567444Nano Safety Research Group, School of Engineering and Physical Sciences, Heriot Watt University, Edinburgh, EH14 4AS UK
| | - Wendel Wohlleben
- grid.3319.80000 0001 1551 0781Department Material Physics and Department of Experimental Toxicology & Ecology, BASF SE, Ludwigshafen, Germany
| | - Agnes G. Oomen
- grid.31147.300000 0001 2208 0118National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands ,grid.7177.60000000084992262Institute for Biodiversity and Ecosystem Dynamics, University of Amsterdam, Amsterdam, The Netherlands
| | - Pier P. Pompa
- grid.25786.3e0000 0004 1764 2907Nanobiointeractions & Nanodiagnostics, Istituto Italiano Di Tecnologia (IIT), Via Morego, 30, 16163 Genoa, Italy
| | | | - Vicki Stone
- grid.9531.e0000000106567444Nano Safety Research Group, School of Engineering and Physical Sciences, Heriot Watt University, Edinburgh, EH14 4AS UK
| | - Stefania Sabella
- grid.25786.3e0000 0004 1764 2907D3 PharmaChemistry, Nanoregulatory Group, Italian Institute of Technology, Via Morego, 30, 16163 Genoa, Italy
| |
Collapse
|